As CKD progresses, the elevation of serum fibroblast growth factor 23 (FGF23) leads to suppression calcitriol production, consequently inducing hypocalcaemia and stimulating parathyroid hormone (PTH) secretion, ultimately resulting in decreased bone mineral density (BMD) [2]. Here, PTH is linked to chronic kidney disease.